In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CeNeS acquires products from Glaxo Wellcome

Executive Summary

CeNeS Pharmaceuticals (CNS therapeutics) has acquired rights in the UK and Ireland to 3 marketed drugs--Diconal, Cyclimorph, and Valoid--from Glaxo Wellcome for £10mm ($15.3mm) in cash.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies